Thomas Ulich
2017
In 2017, Thomas Ulich earned a total compensation of $1.2M as Former Chief Scientific Officer at InVivo Therapeutics Holdings, a 149% increase compared to previous year.
Compensation breakdown
| Option Awards | $533,873 |
|---|---|
| Salary | $254,788 |
| Other | $367,020 |
| Total | $1,155,681 |
Ulich received $533.9K in option awards, accounting for 46% of the total pay in 2017.
Ulich also received $254.8K in salary and $367K in other compensation.
Rankings
In 2017, Thomas Ulich's compensation ranked 8,275th out of 14,666 executives tracked by ExecPay. In other words, Ulich earned more than 43.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,275 out of 14,666 | 44th |
Division Manufacturing | 3,130 out of 5,768 | 46th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 414 out of 856 | 52nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 222 out of 528 | 58th |
Industry Surgical and Medical Instruments and Apparatus | 135 out of 333 | 60th |
Source: SEC filing on April 27, 2018.
Ulich's colleagues
We found six more compensation records of executives who worked with Thomas Ulich at InVivo Therapeutics Holdings in 2017.
2017
Mark Perrin
InVivo Therapeutics Holdings
Chief Executive Officer
2017
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
2017
Tamara Joseph
InVivo Therapeutics Holdings
General Counsel
2017
Christopher McNulty
InVivo Therapeutics Holdings
Chief Financial Officer
2017
Pamela Stahl
InVivo Therapeutics Holdings
Former Chief Commercial Officer
2017
Melanie Morel-Ferris
InVivo Therapeutics Holdings